© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
February 21, 2016
There are more than a dozen treatment options for patients with relapsing multiple sclerosis and so far none for the progressive form. Why that is and what can be done to change that are two of the biggest challenges in the field today.
Some of the finest minds in the field of multiple sclerosis were in New Orleans for the annual ACTRIMS conference all looking to share their knowledge and learn more before returning home to their patients.
February 20, 2016
Trips to the emergency department (ED) can range from the most benign to the most serious of reasons.
As researchers focus on finding treatments for progressive multiple sclerosis there are a number of potential angles to study to find the best treatment options possible. One potential area is the role of B cells in the treatment process.
Recently, researchers had discovered that HIV infection might decrease the risk of developing multiple sclerosis (MS).
New research has discovered high doses of biotin vastly improve neurologic function in a small percentage of patients afflicted with progressive MS.
Gut microbiota has been a trending area of study across all medical specialties, and poses a curious question in multiple sclerosis (MS) research.
February 19, 2016
While newer medications are constantly being developed for multiple sclerosis one of the original options may still be the best for some patients.
As the first medication designed to treat primary progressive multiple sclerosis moves closer to the market there are still many questions about how effective it will be and what other treatment options may look like in the future.
Prior research has shown women suffering from multiple sclerosis (MS) often have a more benign initial course than male patients. However, these same female patients tend to quickly transition to secondary progressive disease as their approach menopause.